Cevidoplenib dimesylate
Cevidoplenib dimesylate is a spleen tyrosine kinase (Syk) inhibitor with anti-inflammatory and immunomodulatory activity. It is used in research for studying autoimmune and inflammatory diseases, with applications in both in vitro cellular assays and in vivo animal models.
Product Specifications
CAS Number
2043659-93-2
Product Name Alternative
Cevidoplenib, Cevidoplenib dimesylate, Cevidoplenib Dimesylate, B-cell, anti-inflammatory, neutrophils, macrophages, inhibit, immunomodulating, Inhibitor, Syk, Spleen tyrosine kinase
Field of Research
Cardiovascular Research, Signal Transduction
Purity
96.16% (May vary between batches)
Solubility
DMSO:20 mg/mL (30.04 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3 mM)
Smiles
CS (O) (=O) =O.CS (O) (=O) =O.Cc1nn (cc1CN1C[C@H] (O) CO1) -c1ccnc (Nc2ccc3n (C) cc (C (=O) C4CC4) c3c2) n1
Molecular Formula
C27H35N7O9S2
Molecular Weight
665.74
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
11310-B1-100 100 µg
Recombinant Human IL-12 R beta 1 His-tag Protein CF
Sign In for Pricing
View Details